Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure

Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure

The review analyzes new treatment for patients with chronic heart failure (CHF) with low ejection fraction – cardiac contractility modulation (CCM). CCM is carried out by supplying electric signals to an absolutely refractory ventricular myocardium, to elicit a positive inotropic effect without incr...

Full description

Bibliographic Details
Main Authors:	A. A. Petrukhina, S. N. Tereshchenko, I. V. Zhirov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-11-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	chronic heart failure implanted devices cardiac contractility modulation
Online Access:	https://www.rpcardio.online/jour/article/view/1339

Similar Items

Enhancing myocardial function with cardiac contractility modulation: potential and challenges
by: Zihan Li, et al.
Published: (2024-02-01)

Cost–utility of cardiac contractility modulation in patients with heart failure with reduced ejection fraction in Italy
by: Maria Lucia Narducci, et al.
Published: (2024-02-01)

Dynamics of heart failure markers and cardiac reverse remodeling in patients receiving cardiac contractility modulation therapy
by: M. A. Vander, et al.
Published: (2021-02-01)

Reverse remodeling against the background of cardiac contractility modulation therapy in patients with heart failure and atrial fibrillation
by: A. A. Safiullina, et al.
Published: (2022-02-01)

Four-year follow-up of a patient with mixed cardiomyopathy and an implanted cardiac contractility modulation device: a case report
by: T. M. Uskach, et al.
Published: (2021-09-01)

Significant improvement of clinical course and reverse myocardial remodeling in young patients with chronic heart failure using cardiac contractility modulation
by: M. A. Vander, et al.
Published: (2019-08-01)

Left ventricular myocardial cellular perfusion against the background of cardiac contractility modulation in patients with heart failure and atrial fibrillation
by: V. A. Amanatova, et al.
Published: (2021-08-01)

Acute Biomechanical Effects of Cardiac Contractility Modulation in Living Myocardial Slices from End-Stage Heart Failure Patients
by: Mark F. A. Bierhuizen, et al.
Published: (2025-02-01)

Application of the Fifth-Generation Cardiac Contractility Modulation Device in a Patient with Chronic Heart Failure: A Case Report
by: Xie C, et al.
Published: (2024-11-01)

Two-year follow-up of patients with heart failure with reduced ejection fraction receiving cardiac contractility modulation
by: M. A. Vander, et al.
Published: (2020-08-01)

Possibilities of Evaluating the Dynamics of Left Ventricular Perfusion and Contractility in Patients with Chronic Heart Failure after Implantation of a Heart Contractility Modulator Using Perfusion Single-Photon Emission Computed Tomography
by: V. A. Amanatova, et al.
Published: (2021-05-01)

Improvement of the technique of positioning the endocardial electrodes of the cardiac contractility modulation device in patients with CHF with reduced ejection fraction and atrial fibrillation
by: Alfiya A. Safiullina, et al.
Published: (2024-07-01)

Implantation of a cardiac contractility modulator in chronic heart failure and atrial fibrillation: results of a 6-month follow-up of one hundred patients
by: T. M. Uskach, et al.
Published: (2021-04-01)

Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapy
by: Aaron B. Hesselson, MD, BSEE, FACC, FHRS, CCDS, et al.
Published: (2024-08-01)

Novel device therapies in heart failure: focus on patient selection
by: Amrita Balgobind, et al.
Published: (2025-02-01)

Spatial adjustment of bioenergetics, a possible determinant of contractile adaptation and development of contractile failure
by: Marten Szibor, et al.
Published: (2023-12-01)

Recent Developments in Cardiac Contractility Modulation for Heart Failure
by: Joshua R. Hirsch, MD, et al.
Published: (2024-09-01)

Yiqi Fumai Lyophilized injection protects cardiac contractility in a rat model of heart failure with reduced ejection fraction by modulating SERCA2
by: Yongwei Nie, et al.
Published: (2025-02-01)

Streamlining Randomized Clinical Trials for Device Therapies in Heart Failure: Bayesian Borrowing of External Data
by: Benjamin R. Saville, et al.
Published: (2024-02-01)

Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction‐associated steatotic liver disease
by: Olufunto O. Badmus, et al.
Published: (2024-05-01)

Device‐therapy in chronic heart failure: Cardiac contractility modulation versus cardiac resynchronization therapy
by: Goekhan Yuecel, et al.
Published: (2025-02-01)

HF Etiology and cardiac contractility modulation therapy
by: Karapet Davtyan, et al.
Published: (2024-05-01)

Myocardial contractile function in the post-traumatic period of cardiac contusion in rats with different stress resistance: A preclinical experimental randomized trial
by: A. N. Zolotov, et al.
Published: (2024-10-01)

Physical rehabilitation in heart failure with reduced ejection fraction: are the cardiac implantable devices a barrier?
by: Bogdan Caloian, et al.
Published: (2023-12-01)

Management of a Patient with Severe Hypotension and Advanced Heart Failure with Reduced Left Ventricular Ejection Fraction
by: M. S. Bychkova, et al.
Published: (2022-03-01)

Novel Medical Treatments and Devices for the Management of Heart Failure with Reduced Ejection Fraction
by: Michele Alfieri, et al.
Published: (2024-04-01)

Mitral valve leaflet clipping in patients with previously implanted heart failure devices
by: Ya. Sh. Karamova, et al.
Published: (2024-10-01)

Optimizing remote heart failure management: First experiences with the HeartInsight score for implanted defibrillators
by: Luca Santini, et al.
Published: (2024-06-01)

EVALUATION CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART FAILURE
by: A. J. Fishman, et al.
Published: (2014-07-01)

WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT?
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Child’s heart development and contractility from prenatal to postnatal period
by: E. N. Pavlyukova, et al.
Published: (2022-02-01)

Device therapies for heart failure with reduced ejection fraction: a new era
by: Rohit Mody, et al.
Published: (2024-10-01)

Efficacy of the Cardiac Implantable Electronic Device Multisensory Triage-HF Algorithm in Heart Failure Care: A Real-World Clinical Experience
by: Ugur Aslan, et al.
Published: (2024-06-01)

Left and right ventricular diastolic dysfunction in patients with coronary heart disease and initial stages of chronic heart failure
by: Z. O. Georgadze, et al.
Published: (1970-01-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Cardiac tissue engineering: an emerging approach to the treatment of heart failure
by: Hossein Rayat Pisheh, et al.
Published: (2024-08-01)

EFFECT OF ALOE VERA GEL ON RAT MYOCARDIAL CONTRACTILITY, CHRONOTROPY AND CORONARY FLOW IN ISOLATED HEART
by: Sadhana Verma, et al.
Published: (2013-09-01)

Ambulatory Risk Stratification for Worsening Heart Failure in Patients with Reduced and Preserved Ejection Fraction Using Diagnostic Parameters Available in Implantable Cardiac Monitors
by: Shantanu Sarkar, et al.
Published: (2024-04-01)

Comorbid conditions in patients with chronic heart failure (according to the registry of chronic heart failure in the Tyumen region)
by: Anna A. Airapetian, et al.
Published: (2023-10-01)

Intraventricular septum role in chronic heart failure pathogenesis
by: N. A. Galanina, et al.
Published: (1970-01-01)